-+ 0.00%
-+ 0.00%
-+ 0.00%

The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered "virtual hearts"

Barchart·12/08/2025 17:19:00
Listen to the news

New CARDIOVERSE project combines AI, stem cells, and genetic variation to predict drug safety before human trials

BAR HARBOR, Maine, Dec. 8, 2025 /PRNewswire/ -- Developing new drugs is one of the riskiest and most expensive endeavors in science. Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 million contract from the Advanced Research Projects Agency for Health (ARPA-H) Computational ADME-Tox and Physiology Analysis for Safer Therapeutics (CATALYST) program. CATALYST is led by ARPA-H Health Science Futures Mission Office Acting Deputy Director Andy Kilianski, Ph.D.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.